{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:47:59Z","timestamp":1790311679312,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-025-10056-0","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T09:57:29Z","timestamp":1750154249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Single-cell spatial proteomics of non-relapse small cell lung cancer identifies tumor microenvironment determinants of survival"],"prefix":"10.1007","volume":"41","author":[{"given":"Yin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghao","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingquan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"3","key":"10056_CR1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.cell.2018.09.018","volume":"175","author":"M Angelova","year":"2018","unstructured":"Angelova M, Mlecnik B, Vasaturo A, Bindea G, Fredriksen T, Lafontaine L, et al. Evolution of Metastases in Space and Time under Immune Selection. Cell. 2018;175(3):751\u2013765 e716. https:\/\/doi.org\/10.1016\/j.cell.2018.09.018.","journal-title":"Cell"},{"issue":"1","key":"10056_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1200\/JCO.1991.9.1.50","volume":"9","author":"E Brambilla","year":"1991","unstructured":"Brambilla E, Moro D, Gazzeri S, Brichon PY, Nagy-Mignotte H, Morel F, et al. Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma. J Clin Oncol. 1991;9(1):50\u201361. https:\/\/doi.org\/10.1200\/JCO.1991.9.1.50.","journal-title":"J Clin Oncol"},{"issue":"3-4","key":"10056_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1615\/CritRevOncog.2016016955","volume":"21","author":"Z Cao","year":"2016","unstructured":"Cao Z, Livas T, Kyprianou N. Anoikis and EMT: Lethal \"Liaisons\" during Cancer Progression. Crit Rev Oncog. 2016;21(3-4):155\u201368. https:\/\/doi.org\/10.1615\/CritRevOncog.2016016955.","journal-title":"Crit Rev Oncog"},{"issue":"10","key":"10056_CR4","doi-asserted-by":"publisher","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7(10):R100. https:\/\/doi.org\/10.1186\/gb-2006-7-10-r100.","journal-title":"Genome Biol"},{"issue":"11","key":"10056_CR5","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.ccell.2021.09.008","volume":"39","author":"JM Chan","year":"2021","unstructured":"Chan JM, Quintanal-Villalonga A, Gao VR, Xie Y, Allaj V, Chaudhary O, et al. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell. 2021;39(11):1479\u20131496 e1418. https:\/\/doi.org\/10.1016\/j.ccell.2021.09.008.","journal-title":"Cancer Cell"},{"key":"10056_CR6","doi-asserted-by":"publisher","unstructured":"Chen H, Deng C, Gao J, Wang J, Fu F, Wang Y, et al. Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer. Cancer Cell. 2025; https:\/\/doi.org\/10.1016\/j.ccell.2025.01.012.","DOI":"10.1016\/j.ccell.2025.01.012"},{"issue":"1","key":"10056_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed A, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8(1):207. https:\/\/doi.org\/10.1038\/s41392-023-01452-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10056_CR8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18(12):792\u2013804. https:\/\/doi.org\/10.1038\/s41571-021-00546-5.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10056_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81\u201394. https:\/\/doi.org\/10.1038\/nrclinonc.2017.166.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10056_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00408-022-00549-8","volume":"200","author":"F Doerr","year":"2022","unstructured":"Doerr F, Stange S, Michel M, Schlachtenberger G, Menghesha H, Wahlers T, et al. Stage I and II Small-Cell Lung Cancer-New Challenge for Surgery. Lung. 2022;200(4):505\u201312. https:\/\/doi.org\/10.1007\/s00408-022-00549-8.","journal-title":"Lung"},{"issue":"12","key":"10056_CR11","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.6004\/jnccn.2021.0058","volume":"19","author":"AKP Ganti","year":"2021","unstructured":"Ganti AKP, Loo BW, Bassetti M, Blakely C, Chiang A, D'Amico TA, et al. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19(12):1441\u201364. https:\/\/doi.org\/10.6004\/jnccn.2021.0058.","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"10056_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrc.2017.87","volume":"17","author":"AF Gazdar","year":"2017","unstructured":"Gazdar AF, Bunn PA, Minna JD. Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer. 2017;17(12):725\u201337. https:\/\/doi.org\/10.1038\/nrc.2017.87.","journal-title":"Nat Rev Cancer"},{"issue":"7796","key":"10056_CR13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41586-019-1876-x","volume":"578","author":"HW Jackson","year":"2020","unstructured":"Jackson HW, Fischer JR, Zanotelli VRT, Ali HR, Mechera R, Soysal SD, et al. The single-cell pathology landscape of breast cancer. Nature. 2020;578(7796):615\u201320. https:\/\/doi.org\/10.1038\/s41586-019-1876-x.","journal-title":"Nature"},{"issue":"5","key":"10056_CR14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2017.07.025","volume":"170","author":"A Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez A, Memon D, Pourpe S, Veeraraghavan H, Li Y, Vargas HA, et al. Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient. Cell. 2017;170(5):927\u2013938 e920. https:\/\/doi.org\/10.1016\/j.cell.2017.07.025.","journal-title":"Cell"},{"issue":"1","key":"10056_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40880-018-0272-5","volume":"38","author":"K Jin","year":"2018","unstructured":"Jin K, Zhang K, Zhou F, Dai J, Zhang P, Jiang G. Selection of candidates for surgery as local therapy among early-stage small cell lung cancer patients: a population-based analysis. Cancer Commun (Lond). 2018;38(1):5. https:\/\/doi.org\/10.1186\/s40880-018-0272-5.","journal-title":"Cancer Commun (Lond)"},{"issue":"7948","key":"10056_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","volume":"614","author":"E Karimi","year":"2023","unstructured":"Karimi E, Yu MW, Maritan SM, Perus LJM, Rezanejad M, Sorin M, et al. Single-cell spatial immune landscapes of primary and metastatic brain tumours. Nature. 2023;614(7948):555\u201363. https:\/\/doi.org\/10.1038\/s41586-022-05680-3.","journal-title":"Nature"},{"issue":"3","key":"10056_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1053\/j.seminoncol.2015.02.009","volume":"42","author":"S Labiano","year":"2015","unstructured":"Labiano S, Palazon A, Melero I. Immune response regulation in the tumor microenvironment by hypoxia. Semin Oncol. 2015;42(3):378\u201386. https:\/\/doi.org\/10.1053\/j.seminoncol.2015.02.009.","journal-title":"Semin Oncol"},{"issue":"3","key":"10056_CR18","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1073\/pnas.90.3.999","volume":"90","author":"D Lazard","year":"1993","unstructured":"Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci U S A. 1993;90(3):999\u20131003. https:\/\/doi.org\/10.1073\/pnas.90.3.999.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10056_CR19","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/annonc\/mdw036","volume":"27","author":"ES Lee","year":"2016","unstructured":"Lee ES, Jung SY, Kim JY, Kim JJ, Yoo TK, Kim YG, et al. Identifying the potential long-term survivors among breast cancer patients with distant metastasis. Ann Oncol. 2016;27(5):828\u201333. https:\/\/doi.org\/10.1093\/annonc\/mdw036.","journal-title":"Ann Oncol"},{"issue":"12 Pt 1","key":"10056_CR20","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1158\/1078-0432.CCR-1052-03","volume":"10","author":"R Li","year":"2004","unstructured":"Li R, Heydon K, Hammond ME, Grignon DJ, Roach M 3rd, Wolkov HB, et al. Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in radiation therapy oncology group protocol 86-10. Clin Cancer Res. 2004;10(12 Pt 1):4118\u201324. https:\/\/doi.org\/10.1158\/1078-0432.CCR-1052-03.","journal-title":"Clin Cancer Res"},{"key":"10056_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati M, Curtale G, Mantovani A. Diversity, Mechanisms, and Significance of Macrophage Plasticity. Annu Rev Pathol. 2020;15:123\u201347. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012718.","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"10056_CR22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg MEW, Scheeren FA, Schumacher TN. The CD47-SIRPalpha Immune Checkpoint. Immunity. 2020;52(5):742\u201352. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.011.","journal-title":"Immunity"},{"issue":"4","key":"10056_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2025.02.027","volume":"58","author":"FX Mauvais","year":"2025","unstructured":"Mauvais FX, Hamel Y, Silvin A, Mulder K, Hildner K, Akyol R, et al. Metallophilic marginal zone macrophages cross-prime CD8(+) T cell-mediated protective immunity against blood-borne tumors. Immunity. 2025;58(4):843\u2013860 e820. https:\/\/doi.org\/10.1016\/j.immuni.2025.02.027.","journal-title":"Immunity"},{"issue":"5","key":"10056_CR24","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.celrep.2018.06.110","volume":"24","author":"I Miller","year":"2018","unstructured":"Miller I, Min M, Yang C, Tian C, Gookin S, Carter D, Spencer SL. Ki67 is a Graded Rather than a Binary Marker of Proliferation versus Quiescence. Cell Rep. 2018;24(5):1105\u20131112 e1105. https:\/\/doi.org\/10.1016\/j.celrep.2018.06.110.","journal-title":"Cell Rep"},{"issue":"8036","key":"10056_CR25","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41586-024-08087-4","volume":"634","author":"CK Mo","year":"2024","unstructured":"Mo CK, Liu J, Chen S, Storrs E, Targino da Costa ALN, Houston A, et al. Tumour evolution and microenvironment interactions in 2D and 3D space. Nature. 2024;634(8036):1178\u201386. https:\/\/doi.org\/10.1038\/s41586-024-08087-4.","journal-title":"Nature"},{"issue":"7","key":"10056_CR26","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jtho.2019.03.028","volume":"14","author":"P Muppa","year":"2019","unstructured":"Muppa P, Parrilha Terra SBS, Sharma A, Mansfield AS, Aubry MC, Bhinge K, et al. Immune Cell Infiltration May Be a Key Determinant of Long-Term Survival in Small Cell Lung Cancer. J Thorac Oncol. 2019;14(7):1286\u201395. https:\/\/doi.org\/10.1016\/j.jtho.2019.03.028.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10056_CR27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1182\/blood-2011-02-339911","volume":"119","author":"OM Pello","year":"2012","unstructured":"Pello OM, De Pizzol M, Mirolo M, Soucek L, Zammataro L, Amabile A, et al. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology. Blood. 2012;119(2):411\u201321. https:\/\/doi.org\/10.1182\/blood-2011-02-339911.","journal-title":"Blood"},{"issue":"3","key":"10056_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/JTO.0000000000000092","volume":"9","author":"G Pelosi","year":"2014","unstructured":"Pelosi G, Rindi G, Travis WD, Papotti M. Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice. J Thorac Oncol. 2014;9(3):273\u201384. https:\/\/doi.org\/10.1097\/JTO.0000000000000092.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10056_CR29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jtho.2019.01.008","volume":"14","author":"JL Pujol","year":"2019","unstructured":"Pujol JL, Greillier L, Audigier-Valette C, Moro-Sibilot D, Uwer L, Hureaux J, et al. A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial. J Thorac Oncol. 2019;14(5):903\u201313. https:\/\/doi.org\/10.1016\/j.jtho.2019.01.008.","journal-title":"J Thorac Oncol"},{"issue":"7","key":"10056_CR30","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, et al. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. Cell. 2017;171(7):1611\u20131624 e1624. https:\/\/doi.org\/10.1016\/j.cell.2017.10.044.","journal-title":"Cell"},{"issue":"11","key":"10056_CR31","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337. https:\/\/doi.org\/10.1038\/nm.3394.","journal-title":"Nat Med"},{"issue":"6","key":"10056_CR32","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.annonc.2021.02.025","volume":"32","author":"J Remon","year":"2021","unstructured":"Remon J, Aldea M, Besse B, Planchard D, Reck M, Giaccone G, Soria JC. Small cell lung cancer: a slightly less orphan disease after immunotherapy. Ann Oncol. 2021;32(6):698\u2013709. https:\/\/doi.org\/10.1016\/j.annonc.2021.02.025.","journal-title":"Ann Oncol"},{"issue":"9","key":"10056_CR33","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nmeth.4391","volume":"14","author":"D Schapiro","year":"2017","unstructured":"Schapiro D, Jackson HW, Raghuraman S, Fischer JR, Zanotelli VRT, Schulz D, et al. histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. Nat Methods. 2017;14(9):873\u20136. https:\/\/doi.org\/10.1038\/nmeth.4391.","journal-title":"Nat Methods"},{"issue":"12","key":"10056_CR34","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.jtho.2019.08.009","volume":"14","author":"T Sen","year":"2019","unstructured":"Sen T, Della Corte CM, Milutinovic S, Cardnell RJ, Diao L, Ramkumar K, et al. Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC. J Thorac Oncol. 2019;14(12):2152\u201363. https:\/\/doi.org\/10.1016\/j.jtho.2019.08.009.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10056_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334. https:\/\/doi.org\/10.3322\/caac.21551.","journal-title":"CA Cancer J Clin"},{"issue":"7948","key":"10056_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41586-022-05672-3","volume":"614","author":"M Sorin","year":"2023","unstructured":"Sorin M, Rezanejad M, Karimi E, Fiset B, Desharnais L, Perus LJM, et al. Single-cell spatial landscapes of the lung tumour immune microenvironment. Nature. 2023;614(7948):548\u201354. https:\/\/doi.org\/10.1038\/s41586-022-05672-3.","journal-title":"Nature"},{"issue":"5","key":"10056_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.annonc.2021.01.071","volume":"32","author":"DR Spigel","year":"2021","unstructured":"Spigel DR, Vicente D, Ciuleanu TE, Gettinger S, Peters S, Horn L, et al. Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331(\u2606). Ann Oncol. 2021;32(5):631\u201341. https:\/\/doi.org\/10.1016\/j.annonc.2021.01.071.","journal-title":"Ann Oncol"},{"issue":"4","key":"10056_CR38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2217\/fon.13.213","volume":"10","author":"A Tartarone","year":"2014","unstructured":"Tartarone A, Lerose R, Ardito R, Troiani L, Tedesco B, Bozza G, et al. Long-term survival in small cell lung cancer: a case report and review of the literature. Future Oncol. 2014;10(4):523\u20138. https:\/\/doi.org\/10.2217\/fon.13.213.","journal-title":"Future Oncol"},{"issue":"2","key":"10056_CR39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/gutjnl-2023-330480","volume":"73","author":"CWF van Eijck","year":"2024","unstructured":"van Eijck CWF, Mustafa DAM, Vadgama D, de Miranda N, Groot Koerkamp B, van Tienhoven G, et al. Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer. Gut. 2024;73(2):311\u201324. https:\/\/doi.org\/10.1136\/gutjnl-2023-330480.","journal-title":"Gut"},{"key":"10056_CR40","doi-asserted-by":"publisher","first-page":"587581","DOI":"10.3389\/fimmu.2020.587581","volume":"11","author":"F Velotti","year":"2020","unstructured":"Velotti F, Barchetta I, Cimini FA, Cavallo MG. Granzyme B in Inflammatory Diseases: Apoptosis, Inflammation, Extracellular Matrix Remodeling, Epithelial-to-Mesenchymal Transition and Fibrosis. Front Immunol. 2020;11:587581. https:\/\/doi.org\/10.3389\/fimmu.2020.587581.","journal-title":"Front Immunol"},{"issue":"4","key":"10056_CR41","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/eji.1830220426","volume":"22","author":"F Velotti","year":"1992","unstructured":"Velotti F, Palmieri G, D'Ambrosio D, Piccoli M, Frati L, Santoni A. Differential expression of granzyme A and granzyme B proteases and their secretion by fresh rat natural killer cells (NK) and lymphokine-activated killer cells with NK phenotype (LAK-NK). Eur J Immunol. 1992;22(4):1049\u201353. https:\/\/doi.org\/10.1002\/eji.1830220426.","journal-title":"Eur J Immunol"},{"issue":"3","key":"10056_CR42","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.lungcan.2015.10.019","volume":"90","author":"G Veronesi","year":"2015","unstructured":"Veronesi G, Bottoni E, Finocchiaro G, Alloisio M. When is surgery indicated for small-cell lung cancer? Lung Cancer. 2015;90(3):582\u20139. https:\/\/doi.org\/10.1016\/j.lungcan.2015.10.019.","journal-title":"Lung Cancer"},{"issue":"1","key":"10056_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jtho.2022.10.002","volume":"18","author":"Q Wang","year":"2023","unstructured":"Wang Q, Gumus ZH, Colarossi C, Memeo L, Wang X, Kong CY, Boffetta P. SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection. J Thorac Oncol. 2023b;18(1):31\u201346. https:\/\/doi.org\/10.1016\/j.jtho.2022.10.002.","journal-title":"J Thorac Oncol"},{"key":"10056_CR44","doi-asserted-by":"publisher","first-page":"670324","DOI":"10.3389\/fimmu.2021.670324","volume":"12","author":"W Wang","year":"2021","unstructured":"Wang W, Zou R, Qiu Y, Liu J, Xin Y, He T, Qiu Z. Interaction Networks Converging on Immunosuppressive Roles of Granzyme B: Special Niches Within the Tumor Microenvironment. Front Immunol. 2021;12:670324. https:\/\/doi.org\/10.3389\/fimmu.2021.670324.","journal-title":"Front Immunol"},{"issue":"7980","key":"10056_CR45","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41586-023-06498-3","volume":"621","author":"XQ Wang","year":"2023","unstructured":"Wang XQ, Danenberg E, Huang CS, Egle D, Callari M, Bermejo B, et al. Spatial predictors of immunotherapy response in triple-negative breast cancer. Nature. 2023a;621(7980):868\u201376. https:\/\/doi.org\/10.1038\/s41586-023-06498-3.","journal-title":"Nature"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10056-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-025-10056-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10056-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T09:57:30Z","timestamp":1750154250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-025-10056-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10056"],"URL":"https:\/\/doi.org\/10.1007\/s10565-025-10056-0","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is a retrospective analysis without any intervention. All human specimens and clinical information used in this study had received approval from the Institutional Review Board (IRB) of Shanghai Chest Hospital (IS21118, approved on November 8, 2020), and was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"106"}}